![](https://investorshub.advfn.com/uicon/33511.png?cb=1696427377)
Friday, October 02, 2015 6:42:40 AM
to make it over the finish line
and the game changes on a NY dime
just maybe, there is enough compelling and immediate advancements on ESS to warranted freezing all programs - putting the emergency brakes on all programs for the sake of 1 is not only strange, but highly unusual...
![](http://imageshack.com/a/img911/5244/mvJRIB.png )
just wish a reputable IB would agree with Geralds personal pipe assesment of:
"We remain supremely confident in the strength of our pipeline."
when:
1.) all programs outside ESS are now stalled
2.) AMBS mantra of "eltoprazine is the Company’s lead therapeutic program" has radically changed
3.) they just signed more floorless toxic death spiral convertibles after a massive RS and AS increase to 3.3-Bil. pre-RS
4.) we've all heard this false story many times before of 'it just around the corner'
this continues to wreak of "going it alone" which is all fine and a greater reward for the shareholders in the long run - but also increases the risk if they fail - something which we all just bitterly witnessed with the Series G conversions, $1 shareprice and paultry 9-Mil. Market Cap
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM